Brazilian Drug Shows Promise for Spinal Cord Injury: Early Trial Results Mixed
The article highlights a groundbreaking development in spinal cord injury treatment. Brazilian researcher Tatiana Coelho de Sampaio, along with her team, has developed polylaminin, a drug derived from placental protein. This innovative treatment, applied directly to the spine, has shown the ability to regenerate the spinal cord, restoring movement in patients with paraplegia or quadriplegia. During the experimental phase, patients experienced complete recovery with no adverse effects, enabling them to resume unrestricted daily activities.
John Q. Hosedrinker